Opening Keynote: An Analysis of the Current Landscape of Dry-AMD Therapeutic Development – How to Overcome Current Regulatory & Clinical Hurdles to Moving Promising Agents to the Clinic

Time: 9:00 am
day: Day One


  • Summary of the major therapeutic strategies currently under development
  • What are the key barriers to progress?
  • What does the future of Dry AMD Therapeutic development look like?